Paula Pujols
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paula Pujols has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alejandra Wyss
Department of Geological and Mining Engineering. Universidad Politécnica de Madrid
1 shared publication - Ana Belen Alcaide Ocana
Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain
1 shared publication - Ana Ezponda
Department of Radiology, Clinica Universidad de Navarra, 31008 Pamplona, Spain
1 shared publication - Arantza Campo
Pulmonary Department. Clínica Universidad de Navarra, Pamplona (Navarra), Spain
1 shared publication - Edgar Fernando Guillén
Nuclear Medicine Department, University of Navarra Clinic, Pamplona, Spain
1 shared publication - Gorka Bastarrika
Radiology Department Clínica Universidad de Navarra Avenida de Pio xII, 36 ES31008 Pamplona Navarra Spain
1 shared publication
Latest Publications
- 20 March 2023
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 29 (10) , 1100-1108
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients
To address the feasibility of implementing a lung cancer screening program in liver transplant recipients (LTR) targeted to detect early-stage lung cancer one hundred twenty-four LTR (89% male, 59.8+/−8.8 y old), who entered the lung cancer screening program at our hospital were reviewed. The results of the diagnostic algorithm using low-dose CT and F-18-fluorodeoxyglycose positron emission tomography (FDG-PET) were analyzed. Lung cancer was detected in 12 LTR (9.7%), most of which corresponded to the non-small cell subtype. Two of the 12 lung cancers were detected in the baseline study (prevalence of 1.6%), whereas 10 patients were diagnosed with lung cancer in the follow-up (incidence of 8.1%). Considering all cancers, 10 of 12 (83.3%) were diagnosed at stage I, one cancer was diagnosed at stage IIIA, and another one at stage IV. The sensitivity, specificity, diagnostic accuracy, and positive and negative predictive values of F-18-fluorodeoxyglycose positron emission tomography to detect malignancy in our cohort were 81.8%,100%, 99.3%, 100%, and 99.3%, respectively. A carefully followed multidisciplinary lung cancer screening algorithm in LTR that includes F-18-fluorodeoxyglycose positron emission tomography and low-dose CT allows lung cancer to be diagnosed at an early stage while reducing unnecessary invasive procedures.
- 20 March 2023
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 29 (10) , 1100-1108
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients
To address the feasibility of implementing a lung cancer screening program in liver transplant recipients (LTR) targeted to detect early-stage lung cancer one hundred twenty-four LTR (89% male, 59.8+/−8.8 y old), who entered the lung cancer screening program at our hospital were reviewed. The results of the diagnostic algorithm using low-dose CT and F-18-fluorodeoxyglycose positron emission tomography (FDG-PET) were analyzed. Lung cancer was detected in 12 LTR (9.7%), most of which corresponded to the non-small cell subtype. Two of the 12 lung cancers were detected in the baseline study (prevalence of 1.6%), whereas 10 patients were diagnosed with lung cancer in the follow-up (incidence of 8.1%). Considering all cancers, 10 of 12 (83.3%) were diagnosed at stage I, one cancer was diagnosed at stage IIIA, and another one at stage IV. The sensitivity, specificity, diagnostic accuracy, and positive and negative predictive values of F-18-fluorodeoxyglycose positron emission tomography to detect malignancy in our cohort were 81.8%,100%, 99.3%, 100%, and 99.3%, respectively. A carefully followed multidisciplinary lung cancer screening algorithm in LTR that includes F-18-fluorodeoxyglycose positron emission tomography and low-dose CT allows lung cancer to be diagnosed at an early stage while reducing unnecessary invasive procedures.